Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder

Life Sciences

Volumn 64, Issue 6-7, 1999, Pages 419-428

  Hegde, Sharath S ^a   Eglen, Richard M ^a  

^a Center for Biological Research   (United States)

Author keywords

Bladder; Detrusor; Incontinence; M2 muscarinic receptors; M3 muscarinic receptors; Muscarinic receptors

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; 11 [[4 [4 (DIETHYLAMINO)BUTYL] 1 PIPERIDYL]ACETYL] 5,11 DIHYDRO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPIN 6 ONE; 4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; ADENYLATE CYCLASE; ATROPINE; CYCLIC AMP; DARIFENACIN; GUANINE NUCLEOTIDE BINDING PROTEIN; HEXAHYDROSILADIFENIDOL DERIVATIVE; HIMBACINE; METHOCTRAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PIRENZEPINE; RECEPTOR SUBTYPE; TRIPITRAMINE;

ACETYLCHOLINE RELEASE; BLADDER CONTRACTION; CONFERENCE PAPER; DETRUSOR MUSCLE; FACILITATION; HUMAN; NEUROGENIC BLADDER; NONHUMAN; PHOSPHOINOSITIDE METABOLISM; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; URGE INCONTINENCE; URINE INCONTINENCE; XEROSTOMIA;

ANIMALS; BINDING SITES; HUMANS; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; URINARY BLADDER;

EID: 0033534579     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00581-5     Document Type: Conference Paper

References (60)

1. W. C. De Groat, A. M. Booth and N. Yoshimura, Nervous Control of the Urogenital System', C. A. Maggi, (ed), 227-290, Harwood Academic Publishers, (1993)
2. C. H. V. Hoyle, and G. Burnstock, Nervous Control of the Urogenital Tract, C. A. Maggi (ed), 349-381, Harwood Academic Publishers (1993)
3. A. J. Wein, J. Am. Geriatric. Soc. 38 317-328 (1990).
4. R. M. Eglen., S. S. Hegde and N. Watson, Pharmacol. Rev. 48 531-565 (1996).
5. R. M. Eglen and S. S. Hegde. Muscarinic Receptor Subtypes in Smooth Muscle, R. M. Eglen (ed), 149-160, CRC Press, Inc, NY. (1997).
6. F. J. Ehlert., R. S. Ostrom, and G. W. Sawyer, Life. Sc. 61 1729-1740 (1997).
7. A. Maeda, T. Kubo, M. Masayoshi, and N. Shosaku, Tissue distribution of mRNA's encoding muscarinic acetylcholine receptor subtypes. FEBS Lett. 239 339-342 (1988).
8. H. Mimata, Y-Nomura, A. Emoto, J. Latifpour, M. Wheeler, and R. M. Weiss, Int. J. Urol. 4 591-596 (1997).
9. O. Yamaguchi, K. Shishido, K. Tamura, T. Ogawa, T. Fujimura and M. Ohtsuka. J. Urol. 156 1208-1213 (1996).
10. A. S. Braverman, I. J. Kohn, G. R. Luthin. and M. R. Ruggieri. Am. J. Physiol. 274 R 517-R 523 (1998).
11. S. J. Wall, R. P. Yasuda, M. Li. and B. B. Wolfe. Mol. Pharmacol, 40 783-789.
12. P. Wang, G. R. Luthin, and M. R. Ruggieri, J. Pharmacol. Exp. Ther. 273 959-966 (1995).
13. L. Nilvebrant, K-E. Andersson. and A. Mattiasson. J. Urol. 134 418-423 (1985).
14. S. Batra, A. Bjorklund, H. Hedlund. and K-E. Andersson, J. Auton. Nerv. Sys. 20 129-135 (1987).
15. S. Batra, Eur. J. Pharmacol, 138 83-88 (1987).
16. L. Nilvebrant, and B. Sparf, Acta Pharmacol. Toxicol, 52 30-38 (1983).
17. E. Monferini, E. Giraldo and H. Ladinsky, Eur. J. Pharmacol. 147 453-458 (1988).
18. M. Goepel, A. Gronewald, S. Krege, and M. C. Michel. Urol. Res. 26 149-154 (1998).
19. M. R. Ruggieri, D. C. Bode, M. R. Levin, and A. J. Wein, Neurourol. Urodyn. 6 119-128 (1987).
20. S. Kondo, T. Morita, and Y. Tashima, Urol. Int. 54 150-153 (1995).
21. S. Mutoh, J. Latifpour, M. Saito. and R. M. Weiss, J. Urol, 157 717-721 (1997).
22. L. Nilvebrant. and B. Sparf. Eur. J. Pharmacol, 151 83-96 (1988).
23. H. Kiwamoto, F-H. Ma, H. Higashira, N. Taniguchi, Y. Ukai, K. Kimura, T. Hanai, K. Hashimoto, T. Sugiyama, Y. C. Park, and T. Kurita, Neurourol. Urodyn. 16 abst. 10 (1997).
24. E. K. Pedder, P. Eveleigh, D. Poyner, E. C. Hulme and N. J. M. Birdsall, Br. J. Pharmacol. 103 1561-1567 (1991).
25. A. Chiarini, R. Budriesi, N. L. Bolognesi, A. Minarini. and C. Melchiorre, Br. J. Pharmacol. 114 1507-1517 (1995).
26. N. Watson, Q. Chan, R. Bailon, A. Choppin, D. Loury, D. Bonhaus, S. S. Hegde. and R. M. Eglen, Faseb. J. 12 abst. 821 (1998).
27. L. Noronha-Blob, V. C. Lowe, A. Patton, B. Canning, D. Costello, and W. J. Kinnier, J. Pharmacol. Exp. Ther. 249 843-851 (1989).
28. K-E. Anderson, F. Holmquist, M. Fovaeus, H. Hedlund, and R. Sundler, J. Urol. 146 1156-1159 (1991).
29. K. A. Marsh, D. R. Harriss. and S. J. Hill, J. Urol. 155 1439-1443 (1996).
30. D. R. Harriss, K. A. Marsh, A. T. Birmingham, and S. J. Hill, J. Urol. 154 1241-1245 (1995).
31. D. V. Daniels, T. D. Meloy, D. Loury, D. Bonhaus, N. Watson, S. S. Hegde A. P. D. W. Ford, and R. M. Eglen, Life. Sci, 1998 (this issue).
32. T. B. Bolton. and A, V. Zholos, Life. Sc. 60 1121-1128 (1997).
33. W. C. Cole. A. Carl. and K. M. Sanders, Amer. J. Physiol. 257 C 481- C 487 (1989).
34. A. D. Bonev. and M. T. Nelson, Am. J. Physiol. 265 C 1723 - C 1728 (1993).
35. T. Nakamura, O. Yamaguchi and J. Kimura, Neurourol. Urodyn. 17 400-401 (1998).
36. H. Togashi, C. W. Emala, I. P. Hall, and C. A. Hirshman, Am. J. Physiol. 274 L803-L809 (1998).
37. P. A. Longhurst, R. E. Leggett, and J. A. K. Briscoe, J. Br. J. Pharmacol. 116 2279-2285 (1995).
38. S. S. Hegde, A. Choppin, D. Bonhaus, S. Briaud, M. Loeb, T. M. Moy, D. Loury. and R. M. Eglen, Br. J. Pharmacol, 120 1409-1418 (1997).
39. G. Tobin, and C. Sjogren, Eur. J. Pharmacol. 281 1-8 (1995).
40. P. A. C. Durant, N. P. Shankley, N. J. Welsh, and J. W. Black, Br. J. Pharmacol. 104 145-150 (1991).
41. F. M. Lai, A. Cobuzzi. and W. Spinelli, Life. Sc. 62 1179-1186 (1998).
42. D. T. Newgreen. and A. M. Naylor, Br. J. Pharmacol. 119 abst. 45P (1996).
43. A. S. Braverman, G. R. Luthin. and M. R. Ruggieri, Soc. For Neurosci. 23 abst. 781.16 (1997).
44. A. S. Braverman, G. R. Luthin, M. A. Pontari. and M. R. Ruggieri, J. Urol. 159 abst. 312 (1998).
45. G. D' Agostino, H. Kilbinger, M. C. Chiari. and E. Grana, J. Pharmacol Exp. Ther. 239 522-528 (1986).
46. G. T. Somogyi, and W. C. De Groat, J. Auton. Nerv. Syst. 37 89-88 (1992).
47. G. Tobin. and C. J. Sjogren, J. Aut. Nerv. Sys. 68 153-156 (1998).
48. G. T. Somogyi, H. D. Flood, M. F. Bellinger. and W. C. De Groat, Soc. For. Neurosc. 22 abst. 45.4 (1996).
49. G. T. Somogyi, G. V. Zernova, M. Tanowitz, and W. C. De Groat, J. Physiol, 499.3 645-654 (1997).
50. P. Alberts, J. Pharmacol. Exp. Ther. 274 458-468 (1995).
51. G. D-Agostino, A. Barbieri, E. Chiossa, and M. Tonini, J. Pharmacol. Exp. Ther. 283 750-756 (1997).
52. Y. E. Yarker, K. L. Goa. and A. Fitton, Drugs & Aging, 6 243-262 (1995).
53. J. G. Blaivas, K. B. Labib, S. K. Michalik, A. A. H. Zayed, J. Urol. 124 259-262 (1980).
54. L. Nilvebrant, B. Hallen, and G. Larsson, Life. Sci. 60 1129 - 1136 (1997)
55. P. Abrams, R. Freeman, C. Anderstorm and A. Mattiasson, Br. J. Urol. 81 801-810 (1998).
56. V. A. Alabaster, Life. Sci. 60 1053-1060 (1997).
57. Y. Homma, Y. Asoi, K. Kawabe, Y. Kumamoto, M. Tsuchida, O. Nishizawa, J. Shimazaki, K. Yasuda, T. Kurita, J. Kumazawa, H. Yamashita, and study group, Neurourol. Urodyn. 16 345-346 (1997).
58. H. Osayu, T. Yamamoto, N. Sato, T. Sawada, R. Ozaki, T. Mukai, T. Ozaki, M. Nishii, H. Sato, T. Fujiwara, Z. Tozuka, Y. Koibuchi, T. Honbo, K. Esumi, M. Ohtsuka, and K. Shimomura, Arzneim-Forsch/Drug. Res. 44 1242-1249 (1994).
59. Th International Symposium of Medicinal Chemistry, abs. 2.28. (1996).
60. J. G. Susset, D. M. Gleason, C. F. White, D. Munoz, M. C. Gittleman, B. H. Wachs, J. S. Brown, D. Knoll, G. S. Friedlander, V. K. Nair, J. Urol. 159 abst. 141 (1998).